Literature DB >> 6245633

Herpes simplex type 1 infection of nonpermissive rat XC cells.

A Epstein, B Jacquemont, J Huppert.   

Abstract

Herpes simplex virus type 1 (HSV-1) infection of non permissive XC cells (a rat cell line transformed by Rous sarcoma virus) was studied. Using virus labeled with 3H-thymidine it was shown that adsorption is similar to that in a permissive system. By electron microscopy enveloped particles were observed in cytoplasmic vesicles in XC cells but not in the permissive system. However input viral DNA was degraded both in non permissive cells (XC) and permissive cells (HEp-2) and the degradation products were found incorporated into cellular DNA in the first case or into viral DNA in the second case. In the non permissive XC cells, it was possible to detect a small amount of incorporation of radioactive precursors into the viral DNA, identified by its buoyant density in CsCl of 1.726 g/cm3 and by hybridization with viral DNA. This DNA has the size of the native viral genome and its uptake of radioactive precursors was only partially inhibited by phosphonoacetic acid, a specific inhibitor of HSV-DNA polymerase. With permissive HEp-2 cells in the presence of such inhibitor, the obtained data are roughly the same as with XC cells, both in the presence or in the absence of phosphonoacetic acid. These results suggest that the observed viral DNA synthesis in XC cells is not a true replication but, further, a repair synthesis and, also, that the same events might take place in the permissive system before the onset of viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245633     DOI: 10.1007/bf01320760

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Herpes simplex virus necleic acid synthesis following infection of non-permissive XC cells.

Authors:  R A Padgett; D F Moore; D T Kingsbury
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

2.  Inhibition of herpes simplex virus replication by phosphonoacetic acid.

Authors:  L R Overby; E E Robishaw; J B Schleicher; A Rueter; N L Shipkowitz; J C Mao
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

3.  In vitro synthesis of DNA in nuclei isolated from human lung cells infected with herpes simplex type II virus.

Authors:  A R Kolber
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

4.  DNA repair replication in human embryonic lung cells infected with herpes simplex virus.

Authors:  A K Lorentz; K Munk; G Darai
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

5.  Isolation of herpes simplex virus DNA from the "hirt supernatant".

Authors:  M M Pater; R W Hyman; F Rapp
Journal:  Virology       Date:  1976-12       Impact factor: 3.616

6.  Regulation of herpes simplex virus-induced thymidine kinase.

Authors:  B Garfinkle; B R McAuslan
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

7.  Restriction of herpes simplex virus type 1 replication in oncornavirus-transformed cells.

Authors:  W F Campbell; B K Murray; N Biswal; M Benyesh-Melnick
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

8.  Abortive herpes simplex virus replication in Rous sarcoma virus transformed cells.

Authors:  J J Docherty; W R Mitchell; C J Thompson; A Anthony
Journal:  Proc Soc Exp Biol Med       Date:  1973-11

9.  A new DNA-exonuclease in cells infected with herpes virus: partial purification and properties of the enzyme.

Authors:  J M Morrison; H M Keir
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

10.  Genetic relatedness of type 1 and type 2 herpes simplex viruses.

Authors:  E Kieff; B Hoyer; S Bachenheimer; B Roizman
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

View more
  1 in total

1.  Analysis of DNA synthesis in herpes simplex virus infected cells by dual parameter flow cytometry.

Authors:  M Lehtinen; P Kulomaa; O P Kallioniemi; J Paavonen; P Leinikki
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.